VistaGen Announces Completion of PALISADE-1 Phase 3 Clinical Study of PH94B for the Acute Treatment of Social Anxiety Disorder - Yahoo Finance

Submitted by Anonymous (not verified) on Wed, 06/22/2022 - 12:30

VistaGen Announces Completion of PALISADE-1 Phase 3 Clinical Study of PH94B for the Acute Treatment of Social Anxiety Disorder  Yahoo Finance